J1610 HCPCS code: Injection, glucagon hydrochloride, per 1 mg
J1610 is the HCPCS Level II code for injection, glucagon hydrochloride, per 1 mg. In 2024 Medicare paid an average of $146.60 per service for J1610 across 5,813 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 38% from 2022 to 2024 (9,399 to 5,813 services). In 2024, about 489 clinicians billed Medicare for J1610 for 4,307 beneficiaries; Florida, Arizona, New York accounted for 83% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 1997-01-01 |
Who bills J1610 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 489 |
| Medicare beneficiaries | 4,307 |
| States with claims | 19 |
| Share of services in top 3 states (Florida, Arizona, New York) | 83% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1610, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 9,399 | 7,309 | $165.52 | $130.72 |
| 2023 | 7,315 | 5,590 | $182.17 | $144.81 |
| 2024 | 5,813 | 4,307 | $184.99 | $146.60 |
States with the most J1610 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 3,923 | $147.50 |
| Arizona | 441 | $145.35 |
| New York | 351 | $147.95 |
| Texas | 209 | $143.49 |
| California | 201 | $146.13 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Clinical: Data |
| practitioner claims | 2 | Prescribing Information |
What changed for J1610
- 1986-01-01: J1610 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1610?
J1610 is the HCPCS Level II code for injection, glucagon hydrochloride, per 1 mg. Short descriptor: "Glucagon hydrochloride/1 mg".
How much does Medicare pay for J1610?
In 2024, the average Medicare payment was $146.60 per service (average allowed $184.99).
Does Medicare cover J1610?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J1610 can be billed per day?
3 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J16 codes
- J1600 — Injection, gold sodium thiomalate, up to 50 mg
- J1602 — Injection, golimumab, 1 mg, for intravenous use
- J1611 — Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612 — Injection, glucagon (gvoke), 0.01 mg
- J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
- J1626 — Injection, granisetron hydrochloride, 100 mcg
- J1627 — Injection, granisetron, extended-release, 0.1 mg
- J1628 — Injection, guselkumab, 1 mg
- J1630 — Injection, haloperidol, up to 5 mg
- J1631 — Injection, haloperidol decanoate, per 50 mg
- J1632 — Injection, brexanolone, 1 mg
- J1640 — Injection, hemin, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1610
- Watch J1610 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1610
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.